GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Exagen Inc (NAS:XGN) » Definitions » Bad Debt Percentage of Revenue %

Exagen (Exagen) Bad Debt Percentage of Revenue % : 0.00% (As of Sep. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Exagen Bad Debt Percentage of Revenue %?

Bad Debt Percentage of Revenue % can be used to estimate the company’s bad debt value. If the company’s bad debt percentage is from historical data, the metric can be used as an indicator of a company's receivable management ability. Under the requirements of transparency and accuracy, lower Bad Debt Percentage of Revenue is better.

The historical rank and industry rank for Exagen's Bad Debt Percentage of Revenue % or its related term are showing as below:

XGN's Bad Debt Percentage of Revenue % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median:
* Ranked among companies with meaningful Bad Debt Percentage of Revenue % only.

Exagen Bad Debt Percentage of Revenue % Historical Data

The historical data trend for Exagen's Bad Debt Percentage of Revenue % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exagen Bad Debt Percentage of Revenue % Chart

Exagen Annual Data
Trend Dec22 Dec23
Bad Debt Percentage of Revenue %
Get a 7-Day Free Trial
Medicare Income Percentage of Revenue %
Get a 7-Day Free Trial

ExagenQuarterly Data
Trend Mar23 Jun23 Sep23
Bad Debt Percentage of Revenue %
Get a 7-Day Free Trial
Medicare Income Percentage of Revenue %
Get a 7-Day Free Trial

Competitive Comparison of Exagen's Bad Debt Percentage of Revenue %

For the Diagnostics & Research subindustry, Exagen's Bad Debt Percentage of Revenue %, along with its competitors' market caps and Bad Debt Percentage of Revenue % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exagen  (NAS:XGN) Bad Debt Percentage of Revenue % Calculation

Companies usually use Bad Debt Percentage of Revenue % to estimate their bad debt. The initial estimates of a company's bad debt allowance is typically based upon past performance. The formula is:

Bad Debt Percentage of Revenue %=( Uncollectible sales / Revenue ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exagen  (NAS:XGN) Bad Debt Percentage of Revenue % Explanation

A bad debt expense is recognized when a receivable is no longer collectible because a customer is unable to fulfill their obligation to pay an outstanding debt due to bankruptcy or other financial problems.

The analysis of bad debt should be combined with the allowance and adjustment the company made of the fiscal year. If the company’s Bad Debt Percentage of Revenue % kept increasing, the company’s profitability should be questioned. However, abnormal low ratios are also worth attention because it may be a sign of fiscal report manipulation.

Exagen Bad Debt Percentage of Revenue % Related Terms

Thank you for viewing the detailed overview of Exagen's Bad Debt Percentage of Revenue % provided by GuruFocus.com. Please click on the following links to see related term pages.

Exagen (Exagen) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Exagen Inc (NAS:XGN) » Definitions » Bad Debt Percentage of Revenue %
Comparable Companies
LMDX AKUMQ CNTG STIM CHEK MYNZ OCX TTOO TRIB DRIO TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
E08A:Germany
Address
1261 Liberty Way, Vista, CA, USA, 92081
Website
https://www.exagen.com
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
Executives
John Aballi director, officer: President and CEO C/O DECIPHER BIOSCIENCES, INC., 6925 LUSK BLVD, SUITE 200, SAN DIEGO CA 92121
Paul Kim director 4399 SANTA ANITA AVE, EL MONTE CA 91731
Tullis Growth Fund Ii, L.p. 10 percent owner 11770 US HWY 1, STE 503, PALM BEACH GARDENS FL 33408
Kamal Adawi officer: Chief Financial Officer C/O EXAGEN INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92131
Mark Hazeltine officer: Chief Operating Officer C/O EXAGEN INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92081
Wendy S. Johnson director 800 E. LEIGH STREET, SUITE 209, RICHMOND VA 21219
Tullis James L L director, 10 percent owner 100 FIRST STAMFORD PLACE, STAMFORD CT 06907
Ana Hooker director 441 CHARMANY DRIVE, MADISON WI 53719
Frank Stokes director C/O CASTLE BIOSCIENCES, 820 S. FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD TX 77546
Hunt Holdings Limited Partnership 10 percent owner C/O EXAGEN INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92081
Nmsic Co-investment Fund, L.p. 10 percent owner C/O EXAGEN INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92081
Debra Zack officer: Chief Medical Officer C/O EXAGEN, INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92081
H.i.g. Bio-exagen, L.p. 10 percent owner C/O EXAGEN INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92081
Thierry Dervieux officer: Chief Scientific Officer C/O EXAGEN DIAGNOSTICS, INC., 1261 LIBERTY WAY, VISTA CA 92081
Nmsic Focused Llc 10 percent owner C/O EXAGEN INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92081